2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide

C71H61N11O9S3 — CID 158383908

IUPAC2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide
SMILESCNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc(C(=O)O)cc3)[nH]c2c1.CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc(NC(C)=O)cc3)[nH]c2c1.CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc4cc[nH]c4c3)[nH]c2c1
InChIInChI=1S/C24H22N4O3S.C24H20N4O2S.C23H19N3O4S/c1-16(29)26-19-11-7-17(8-12-19)9-14-24-27-21-13-10-18(15-22(21)28-24)20-5-3-4-6-23(20)32(30,31)25-2;1-25-31(29,30)23-5-3-2-4-19(23)18-9-10-20-22(15-18)28-24(27-20)11-7-16-6-8-17-12-13-26-21(17)14-16;1-24-31(29,30)21-5-3-2-4-18(21)17-11-12-19-20(14-17)26-22(25-19)13-8-15-6-9-16(10-7-15)23(27)28/h3-15,25H,1-2H3,(H,26,29)(H,27,28);2-15,25-26H,1H3,(H,27,28);2-14,24H,1H3,(H,25,26)(H,27,28)/b14-9+;11-7+;13-8+
InChIKeyGWDDARPUGNYJPZ-DHFBXMSCSA-N
MW1308.54 g/mol
LogP13.06
Rot. Bonds17

About 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide

2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide (PubChem CID 158383908) has the molecular formula C71H61N11O9S3 and a molecular weight of 1308.54 g/mol. Its IUPAC name is 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide.

Molecular Properties

Compound Name2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide
PubChem CID158383908
Molecular FormulaC71H61N11O9S3
Molecular Weight1308.54 g/mol
Exact Mass1307.38
IUPAC Name2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide
SMILESCNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc(C(=O)O)cc3)[nH]c2c1.CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc(NC(C)=O)cc3)[nH]c2c1.CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc4cc[nH]c4c3)[nH]c2c1
InChIInChI=1S/C24H22N4O3S.C24H20N4O2S.C23H19N3O4S/c1-16(29)26-19-11-7-17(8-12-19)9-14-24-27-21-13-10-18(15-22(21)28-24)20-5-3-4-6-23(20)32(30,31)25-2;1-25-31(29,30)23-5-3-2-4-19(23)18-9-10-20-22(15-18)28-24(27-20)11-7-16-6-8-17-12-13-26-21(17)14-16;1-24-31(29,30)21-5-3-2-4-18(21)17-11-12-19-20(14-17)26-22(25-19)13-8-15-6-9-16(10-7-15)23(27)28/h3-15,25H,1-2H3,(H,26,29)(H,27,28);2-15,25-26H,1H3,(H,27,28);2-14,24H,1H3,(H,25,26)(H,27,28)/b14-9+;11-7+;13-8+
InChIKeyGWDDARPUGNYJPZ-DHFBXMSCSA-N
XLogP13.06
TPSA306.74 Ų
H-Bond Donors9
H-Bond Acceptors11
Rotatable Bonds17
Heavy Atoms94
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001308.54
LogP ≤ 513.06
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1011

Analyze 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide?
The IUPAC name of 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide (CID 158383908) is 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide.
What is the SMILES notation for 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide?
The canonical SMILES for 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide is CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc(C(=O)O)cc3)[nH]c2c1.CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc(NC(C)=O)cc3)[nH]c2c1.CNS(=O)(=O)c1ccccc1-c1ccc2nc(/C=C/c3ccc4cc[nH]c4c3)[nH]c2c1.
What is the InChIKey of 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide?
The InChIKey is GWDDARPUGNYJPZ-DHFBXMSCSA-N. The full InChI is InChI=1S/C24H22N4O3S.C24H20N4O2S.C23H19N3O4S/c1-16(29)26-19-11-7-17(8-12-19)9-14-24-27-21-13-10-18(15-22(21)28-24)20-5-3-4-6-23(20)32(30,31)25-2;1-25-31(29,30)23-5-3-2-4-19(23)18-9-10-20-22(15-18)28-24(27-20)11-7-16-6-8-17-12-13-26-21(17)14-16;1-24-31(29,30)21-5-3-2-4-18(21)17-11-12-19-20(14-17)26-22(25-19)13-8-15-6-9-16(10-7-15)23(27)28/h3-15,25H,1-2H3,(H,26,29)(H,27,28);2-15,25-26H,1H3,(H,27,28);2-14,24H,1H3,(H,25,26)(H,27,28)/b14-9+;11-7+;13-8+.
What are the key properties of 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide?
2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide has a molecular weight of 1308.54 g/mol, XLogP of 13.06, 17 rotatable bonds, 9 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[(E)-2-(1H-indol-6-yl)ethenyl]-3H-benzimidazol-5-yl]-N-methylbenzenesulfonamide;4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]benzoic acid;N-[4-[(E)-2-[6-[2-(methylsulfamoyl)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]acetamide is sourced from PubChem (CID 158383908), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).